News from nordic nanovector A wide array of domestic and global news stories; news topics include politics/government, business, technology, religion, sports/entertainment, science/nature, and health/lifestyle. Articles that appear in this section may be written in English or other languages

Latest

01 Jul, 2020, 15:39 BST Nordic Nanovector ASA - Share Capital Increase Registered

Nordic Nanovector ASA - share capital increase registered Oslo, Norway, 1 July 2020 Reference is made to the stock exchange notice by Nordic...


01 Jul, 2020, 06:56 BST Nordic Nanovector ASA: Allocation of Restricted Stock Unites (RSUs) to the Board of Directors

Reference is made to the minutes from Nordic Nanovector ASA's (the "Company") (OSE: NANO) annual general meeting held on 10 June 2020 in Oslo, Norway ...


30 Jun, 2020, 06:20 BST Nordic Nanovector to Amend PARADIGME Trial Protocol to Expand Eligible Patient Population

Nordic Nanovector ASA (OSE: NANO) announces that it will amend the trial protocol for its PARADIGME trial to broaden the inclusion criteria and...


29 Jun, 2020, 06:44 BST Nordic Nanovector's Betalutin® Receives Fast-track Designation from US FDA for Marginal Zone Lymphoma

Nordic Nanovector ASA (OSE: NANO) today announces that the US Food and Drug Administration (FDA) has granted Fast Track designation for investigating ...


10 Jun, 2020, 11:22 BST Nordic Nanovector ASA: Annual General Meeting Held

The Annual General Meeting of Nordic Nanovector ASA (the "Company") (OSE: NANO) was held today on 10 June 2020 in Oslo, Norway. All proposals were...


02 Jun, 2020, 07:14 BST Nordic Nanovector to Present at Upcoming Jefferies Virtual Healthcare Conference and ABG Sundal Collier Virtual Oncology Seminar

Nordic Nanovector ASA (OSE: NANO) announces that members of its management team will present at Jefferies Virtual Healthcare Conference, taking place ...


26 May, 2020, 06:16 BST Nordic Nanovector ASA: Results for the First Quarter 2020

Nordic Nanovector ASA (OSE: NANO) announces its results for the first quarter 2020. A presentation by Nordic Nanovector's senior management team will ...


20 May, 2020, 06:54 BST Nordic Nanovector ASA: Notice of Annual General Meeting on 10 June 2020

Notice is given that the Annual General Meeting of Nordic Nanovector ASA will be held on 10 June 2020, at 10:00 hours CEST at Thon Hotel...


20 May, 2020, 06:44 BST Nordic Nanovector ASA Announces Proposed Change of the Nomination Committee

Nordic Nanovector ASA (OSE: NANO) announces that its Nomination Committee has nominated Mr. Pål Erik Robinson for election as a member of the...


19 May, 2020, 18:37 BST Nordic Nanovector ASA: Invitation to First Quarter 2020 Results Webcast

Nordic Nanovector ASA (OSE: NANO) announces that it will report its results for the first quarter 2020 on Tuesday, 26 May 2020. A presentation by...


14 May, 2020, 17:06 BST Nordic Nanovector's Betalutin® Receives Positive Opinion for Orphan Drug Designation from EMA for Marginal Zone Lymphoma (MZL)

Nordic Nanovector ASA (OSE: NANO) today announces that Betalutin® (177Lu lilotomab satetraxetan) has received a positive opinion from the European...


07 May, 2020, 07:09 BST Nordic Nanovector ASA: Increase of Share Capital

Three of the board members of Nordic Nanovector ASA (the "Company"), Gisela Schwab, Joanna Horobin and Jean-Pierre Bizzari have resolved to settle a...


05 May, 2020, 06:59 BST Nordic Nanovector Announces US Patent Granted Covering the use of Betalutin® to Sensitise B-Cell Cancer Cells to CD20 Immunotherapy

Nordic Nanovector ASA (OSE:) is pleased to announce the grant of a US patent covering the use of Betalutin® (177Lu-satetraxetan-lilotomab) for...


04 May, 2020, 16:04 BST Nordic Nanovector Announces Changes to its Executive Management Team

Nordic Nanovector ASA (OSE: NANO) today announces changes to its Executive Management Team. As a result of the cost-saving initiatives announced on 2 ...


08 Apr, 2020, 20:20 BST Nordic Nanovector Announces New Date for Annual General Meeting

Nordic Nanovector ASA (OSE: NANO) today announces a new date for its Annual General Meeting (AGM) as a result of the impact of the ongoing COVID-19...


01 Apr, 2020, 16:29 BST Nordic Nanovector Announces Focus on Advancing PARADIGME and Actions to Extend Cash Runway into 2021

Nordic Nanovector ASA (OSE: NANO) today announces a number of initiatives to speed up recruitment into its pivotal Phase 2b PARADIGME trial with...


27 Mar, 2020, 08:14 GMT Nordic Nanovector ASA Publishes 2019 Annual Report

On 26 March 2020, the Board of Directors of Nordic Nanovector ASA approved the company's financial statements for 2019. The company's 2019 Annual...


24 Mar, 2020, 11:36 GMT Nordic Nanovector ASA - Allocation of PSUs

The Board of Directors of Nordic Nanovector ASA ("Nordic Nanovector" or the "Company") has on 24 March 2020 decided to grant 561,500 Performance...


23 Mar, 2020, 16:43 GMT Nordic Nanovector Appoints Dr Dominic Smethurst as Interim Chief Medical Officer

Nordic Nanovector ASA (OSE: NANO) announces that Dr Dominic Smethurst has been appointed Interim Chief Medical Officer with immediate effect. Dr...


19 Mar, 2020, 17:28 GMT Nordic Nanovector ASA Announces Proposed Board Change

Nordic Nanovector ASA (OSE: NANO) announces that its Nomination Committee has nominated Dr Karin Meyer, PhD for election as a Non-executive Director...


10 Mar, 2020, 06:15 GMT Nordic Nanovector ASA - Financial calendar

Financial calendar for Nordic Nanovector ASA FINANCIAL YEAR 2019 27.03.2020 - Annual Report FINANCIAL YEAR 2020 27.08.2020 - Half-yearly Report 30.04....


27 Feb, 2020, 06:29 GMT Nordic Nanovector ASA - Results for the Fourth Quarter and Full Year 2019

Nordic Nanovector ASA (OSE: NANO) announces its results for the fourth quarter and full year 2019. A presentation by the company's senior management...


27 Feb, 2020, 06:21 GMT Nordic Nanovector ASA - resultat for fjerde kvartal og helår 2019

Nordic Nanovector ASA (OSE: NANO) publiserer i dag sine resultater for fjerde kvartal 2019. Selskapets ledelse vil gi en presentasjon av resultatene...


26 Feb, 2020, 16:16 GMT Nordic Nanovector Appoints Dr Lars Nieba as Interim Chief Executive Officer

Nordic Nanovector ASA (OSE: NANO) announces that Dr Lars Nieba has been appointed interim Chief Executive Officer with immediate effect. Dr Nieba,...


21 Feb, 2020, 16:07 GMT Nordic Nanovector ASA: Invitation to Fourth Quarter and Full Year 2019 Results Presentation and Webcast

Nordic Nanovector ASA (OSE: NANO) announces that it will report its results for the fourth quarter and full year 2019 on Thursday, 27 February 2020....